Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression

European Neuropsychopharmacology

Volumn 19, Issue 11, 2009, Pages 796-805

  Liu, Qiong ^a,b   Li, Bing ^a   Zhu, Hai Yan ^a   Wang, Yan Qing ^a   Yu, Jin ^a   Wu, Gen Cheng ^a  

^a Institutes of Brain Science   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Clomipramine; Depression; GFAP; Glia; Hippocampus

Indexed keywords

CLOMIPRAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; NORADRENALIN; SEROTONIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FORCED SWIMMING TEST; GLIA; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NORADRENALIN UPTAKE; OPEN FIELD TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTONIN UPTAKE; WESTERN BLOTTING;

ANIMALS; CLOMIPRAMINE; DEPRESSION; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FREEZING REACTION, CATALEPTIC; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; MALE; NEUROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 70349625589     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2009.06.010     Document Type: Article

References (65)

1. Alonso R., Griebel G., Pavone G., Stemmelin J., Le Fur G., and Soubrie P. Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression. Molecular Psychiatry 9 (2004) 278-286
2. Bachis A., Cruz M.I., Nosheny R.L., and Mocchetti I. Chronic unpredictable stress promotes neuronal apoptosis in the cerebral cortex. Neuroscience Letters 442 (2008) 104-108
3. Banasr M., and Duman R.S. Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biological Psychiatry 64 10 (2008) 863-870
4. Banasr M., Valentine G.W., Li X.Y., Gourley S.L., Taylor J.R., and Duman R.S. Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biological Psychiatry 62 (2007) 496-504
5. Bondi C.O., Rodriguez G., Gould G.G., Frazer A., and Morilak D.A. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology 33 (2008) 320-331
6. Bowley M.P., Drevets W.C., Ongur D., and Price J.L. Low glial numbers in the amygdala in major depressive disorder. Biological Psychiatry 52 (2002) 404-412
7. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., and Charney D.S. Hippocampal volume reduction in major depression. [see comment]. American Journal of Psychiatry 157 (2000) 115-118
8. Campbell S., and Macqueen G. The role of the hippocampus in the pathophysiology of major depression. Journal of Psychiatry & Neuroscience 29 (2004) 417-426
9. Campbell S., Marriott M., Nahmias C., and MacQueen G.M. Lower hippocampal volume in patients suffering from depression: a meta-analysis. [see comment]. American Journal of Psychiatry 161 (2004) 598-607
10. Casanovas A., Olmos G., Ribera J., Boronat M.A., Esquerda J.E., and Garcia-Sevilla J.A. Induction of reactive astrocytosis and prevention of motoneuron cell death by the I(2)-imidazoline receptor ligand LSL 60101. British Journal of Pharmacology 130 (2000) 1767-1776
11. Cobb J.A., Mahajan G., Lawrence T.J., Miguel-Hidalgo J.J., Dieter L., Herbst N., Matzinger M., Overholser J.C., Jurjus G.J., Rajkowska G., and Stockmeier C.A. Stereological estimation of cell number, cell size, and hippocampal volume in major depressive disorder (MDD. Neuroscience Meeting Planner (2006), Society for Neuroscience, Atlanta, GA Online
12. Cohen Z., Bouchelet I., Olivier A., Villemure J.G., Ball R., Stanimirovic D.B., and Hamel E. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization. Journal of Cerebral Blood Flow & Metabolism 19 (1999) 908-917
13. Cotter D.R., Pariante C.M., and Everall I.P. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Research Bulletin 55 5 (2001) 585-595
14. Cotter D., Mackay D., Chana G., Beasley C., Landau S., and Everall I.P. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cerebral Cortex 12 4 (2002) 386-394
15. Coyle J.T., and Schwarcz R. Mind glue: implications of glial cell biology for psychiatry. Archives of General Psychiatry 57 (2000) 90-93
16. Crawford M.J. Depression: international intervention for a global problem. British Journal of Psychiatry 184 (2004) 379-380
17. Czéh B., and Lucassen P.J. What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated?. European Archives of Psychiatry and Clinical Neuroscience 257 5 (2007) 250-260
18. Czéh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A., and Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proceedings of the National Academy of Sciences of the United States of America 98 22 (2001) 12796-12801
19. Czéh B., Simon M., Schmelting B., Hiemke C., and Fuchs E. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 31 (2006) 1616-1626
20. DeWitt D.A., Perry G., Cohen M., Doller C., and Silver J. Astroglia regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Experimental Neurology 149 (1998) 329-340
21. Forbes N.F., Stewart C.A., Matthews K., and Reid I.C. Chronic mild stress and sucrose consumption: validity as a model of depression. Physiology & Behavior 60 (1996) 1481-1484
22. Frodl T., Meisenzahl E.M., Zetzsche T., Born C., Groll C., Jager M., Leinsinger G., Bottlender R., Hahn K., and Moller H.J. Hippocampal changes in patients with a first episode of major depression. American Journal of Psychiatry 159 (2002) 1112-1118
23. Fuchs E., Czeh B., Kole M.H., Michaelis T., and Lucassen P.J. Alterations of neuroplasticity in depression: the hippocampus and beyond. European Neuropsychopharmacology 14 Suppl 5 (2004) S481-S490
24. Garcia-Segura L.M., Naftolin F., Hutchison J.B., Azcoitia I., and Chowen J.A. Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. Journal of Neurobiology 40 (1999) 574-584
25. Geddes J.R., Burgess S., Hawton K., Jamison K., and Goodwin G.M. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. [see comment]. American Journal of Psychiatry 161 (2004) 217-222
26. Gosselin R.D., Gibney S., O'Malley D., Dinan T.G., and Cryan J.F. Region specific decrease in glial fibrillary acidic protein immunoreactivity in the brain of a rat model of depression. Neuroscience 159 2 (2009) 915-925
27. Griffith R., and Sutin J. Reactive astrocyte formation in vivo is regulated by noradrenergic axons. Journal of Comparative Neurology 371 (1996) 362-375
28. Harrison P.J. The neuropathology of primary mood disorder. Brain 125 (2002) 1428-1449
29. Hirst W.D., Price G.W., Rattray M., and Wilkin G.P. Serotonin transporters in adult rat brain astroglia revealed by [3H]5-HT uptake into glial plasmalemmal vesicles. Neurochemistry International 33 (1998) 11-22
30. Karschin A., Wassle H., and Schnitzer J. Immunocytochemical studies on astroglia of the cat retina under normal and pathological conditions. Journal of Comparative Neurology 249 (1986) 564-576
31. Liu Q., Yu J., Mi W.L., Mao-Ying Q.L., Yang R., Wang Y.Q., and Wu G.C. Electroacupuncture attenuates the decrease of hippocampal progenitor cell proliferation in the adult rats exposed to chronic unpredictable stress. Life Sciences 81 21-22 (2007) 1489-1495
32. Liu Q., Yu J., Mao-Ying Q.L., Mi W.L., Li B., Wang Y.Q., Wang J., and Wu G.C. Repeated clomipramine treatment reversed the inhibition of cell proliferation in adult hippocampus induced by chronic unpredictable stress. Pharmacogenomics Journal 8 (2008) 375-383
33. MacQueen G.M., Campbell S., McEwen B.S., Macdonald K., Amano S., Joffe R.T., Nahmias C., and Young L.T. Course of illness, hippocampal function, and hippocampal volume in major depression. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 1387-1392
34. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 20 24 (2000) 9104-9110
35. Mayer J.L., Klumpers L., Maslam S., de Kloet E.R., Joëls M., and Lucassen P.J. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis. Journal of Neuroendocrinology 18 8 (2006) 629-631
36. Mervaala E., Fohr J., Kononen M., Valkonen-Korhonen M., Vainio P., Partanen K., Partanen J., Tiihonen J., Viinamaki H., Karjalainen A.K., and Lehtonen J. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychological Medicine 30 (2000) 117-125
37. Montgomery S.A. Why do we need new and better antidepressants?. International Clinical Psychopharmacology 21 Suppl 1 (2006) S1-S10
38. Moreau J.L. Validation d'un modele animal de l'anhedonie, symptome majeur de la depression. Encephale 23 (1997) 280-289
39. Muller T., and Kettenmann H. Physiology of Bergmann glial cells. International Review of Neurobiology 38 (1995) 341-359
40. Muller M.B., Lucassen P.J., Yassouridis A., Hoogendijk W.J., Holsboer F., and Swaab D.F. Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. European Journal of Neuroscience 14 (2001) 1603-1612
41. Nelson J.C. A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression. Biological Psychiatry 46 (1999) 1301-1308
42. Okugawa G., Omori K., Suzukawa J., Fujiseki Y., Kinoshita T., and Inagaki C. Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones. Journal of Neuroendocrinology 11 (1999) 887-895
43. Ongur D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 13290-13295
44. Oomen C.A., Mayer J.L., de Kloet E.R., Joëls M., and Lucassen P.J. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalizes the reduction in neurogenesis after chronic stress. European Journal of Neuroscience 26 12 (2007) 3395-3401
45. Panconi E., Roux J., Altenbaumer M., Hampe S., and Porsolt R.D. MK-801 and enantiomers: potential antidepressants or false positives in classical screening models?. Pharmacology, Biochemistry & Behavior 46 (1993) 15-20
46. Percaccio C.R., Engineer N.D., Pruette A.L., Pandya P.K., Moucha R., Rathbun D.L., and Kilgard M.P. Environmental enrichment increases paired-pulse depression in rat auditory cortex. (erratum appears in J Neurophysiol. 2006 Feb;95(2):1293). Journal of Neurophysiology 94 (2005) 3590-3600
47. Phillips R.J., Kieffer E.J., and Powley T.L. Loss of glia and neurons in the myenteric plexus of the aged Fischer 344 rat. Anatomy & Embryology 209 (2004) 19-30
48. Potter W.Z. Adrenoceptors and serotonin receptor function: relevance to antidepressant mechanisms of action. Journal of Clinical Psychiatry 57 Suppl 4 (1996) 4-8
49. Rajkowska G. Cell pathology in mood disorders. Seminars in Clinical Neuropsychiatry 7 (2002) 281-292
50. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., Overholser J.C., Roth B.L., and Stockmeier C.A. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry 45 (1999) 1085-1098
51. Redmond A.M., Kelly J.P., and Leonard B.E. Behavioural and neurochemical effects of dizocilpine in the olfactory bulbectomized rat model of depression. Pharmacology, Biochemistry & Behavior. 58 (1997) 355-359
52. Saletu-Zyhlarz G.M., Anderer P., Arnold O., and Saletu B. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients. Neuropsychobiology 48 (2003) 194-208
53. Selemon L.D., Lidow M.S., and Goldman-Rakic P.S. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biological Psychiatry 46 (1999) 161-172
54. Shah P.J., Ebmeier K.P., Glabus M.F., and Goodwin G.M. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. British Journal of Psychiatry 172 (1998) 527-532
55. Sheline Y.I., Sanghavi M., Mintun M.A., and Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. Journal of Neuroscience 19 (1999) 5034-5043
56. Sheline Y.I., Mittler B.L., and Mintun M.A. The hippocampus and depression. European Psychiatry: the Journal of the Association of European Psychiatrists 17 Suppl 3 (2002) 300-305
57. Sikiric P., Separovic J., Buljat G., Anic T., Stancic-Rokotov D., Mikus D., Marovic A., Prkacin I., Duplancic B., Zoricic I., Aralica G., Lovric-Bencic M., Ziger T., Perovic D., Rotkvic I., Mise S., Hanzevacki M., Hahn V., Seiwerth S., Turkovic B., Grabarevic Z., Petek M., and Rucman R. The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressants. Journal of Physiology, Paris 94 (2000) 99-104
58. Song H., Stevens C.F., and Gage F.H. Astroglia induce neurogenesis from adult neural stem cells. Nature 417 6884 (2002) 39-44
59. Stockmeier C.A., Mahajan G.J., Konick L.C., Overholser J.C., Jurjus G.J., Meltzer H.Y., Uylings H.B., Friedman L., and Rajkowska G. Cellular changes in the postmortem hippocampus in major depression. Biological Psychiatry 56 (2004) 640-650
60. Strauman T.J., Vieth A.Z., Merrill K.A., Kolden G.G., Woods T.E., Klein M.H., Papadakis A.A., Schneider K.L., and Kwapil L. Self-system therapy as an intervention for self-regulatory dysfunction in depression: a randomized comparison with cognitive therapy. Journal of Consulting & Clinical Psychology 74 (2006) 367-376
61. Warner-Schmidt J.L., and Duman R.S. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 16 3 (2006) 239-249
62. Wille S.M., Cooreman S.G., Neels H.M., and Lambert W.E. Relevant issues in the monitoring and the toxicology of antidepressants. Critical Reviews in Clinical Laboratory Sciences 45 (2008) 25-89
63. Wong M.L., and Licinio J. From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nature Reviews Drug Discovery 3 (2004) 136-151
64. Yu J., Liu Q., Wang Y.Q., Wang J., Li X.Y., Cao X.D., and Wu G.C. Electroacupuncture combined with clomipramine enhances antidepressant effect in rodents. Neuroscience Letters 421 1 (2007) 5-9
65. Zhou L.L., Ming L., Ma C.G., Cheng Y., and Jiang Q. Antidepressant-like effects of BCEF0083 in the chronic unpredictable stress models in mice. Chinese Medical Journal 118 (2005) 903-908